Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial progenitor cells for regeneration.

H Masuda1, C Kalka, T Asahara

  • 1Department of Medicine (Cardiovascular Research), St. Elizabeth's Medical Center, Tufts University School of Medicine, USA. hmasuda@sprynet.com

Human Cell
|May 2, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New recommendations on cerebral venous and dural sinus thrombosis from the German consensus-based (S2k) guideline.

Neurological research and practice·2024
Same author

Diagnostics and Therapy of Venous Thrombosis and Pulmonary Embolism. The revised AWMF S2k Guideline

VASA. Zeitschrift fur Gefasskrankheiten·2023
Same author

Venous Leak Embolization in Patients with Venogenic Erectile Dysfunction via Deep Dorsal Penile Vein Access: Safety and Early Efficacy.

Cardiovascular and interventional radiology·2023
Same author

Hamostaseologie·2019
Same author

Impact of long-term corticosteroid therapy on the distribution pattern of lower limb atherosclerosis.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2010
Same author

Clinical predictors of prophylaxis use prior to the onset of acute venous thromboembolism in hospitalized patients SWIss Venous ThromboEmbolism Registry (SWIVTER).

Journal of thrombosis and haemostasis : JTH·2008

Endothelial progenitor cells (EPCs) from blood or bone marrow enhance vascular development in ischemic tissues. These cells offer promising potential for regenerative cell and gene therapies.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Cell Biology

Background:

  • Endothelial progenitor cells (EPCs) are crucial for neovascularization.
  • EPCs can be isolated from peripheral blood and bone marrow.
  • Their role in physiological and pathological neovascularization is increasingly recognized.

Purpose of the Study:

  • To investigate the therapeutic potential of EPCs in enhancing vascular development.
  • To explore EPCs' application in regenerative medicine for ischemic tissues.
  • To evaluate EPCs as a tool for cell-mediated gene therapy.

Main Methods:

  • Isolation of EPCs from peripheral blood and bone marrow.
  • Transplantation of EPCs into ischemic models.
  • Assessment of vascular development and tissue regeneration in vivo.

Related Experiment Videos

  • Evaluation of EPC differentiation and proliferation within ischemic organs.

    • Main Results:

    • Transplanted EPCs were incorporated into sites of neovascularization.
    • EPC transplantation enhanced vascular development in ischemic organs.
    • EPCs differentiated and proliferated in situ within the ischemic tissue.
    • Differentiated endothelial cells (ECs) showed less efficacy compared to EPCs.

    Conclusions:

    • EPCs possess a unique capacity for postnatal neovascularization.
    • EPC transplantation is a viable strategy for regenerating ischemic tissues.
    • EPCs hold significant promise for cell therapy and cell-mediated gene therapy applications.